REPL::Placements::Proposed Subscription of 4,100,000 New Ordinary Shares - Receipt of Approval In-Principle
Issuer & Securities
Issuer/ Manager
PHARMESIS INTERNATIONAL LTD.
Securities
PHARMESIS INTERNATIONAL LTD. - SG1BH6000003 - BFK
Stapled Security
No
Announcement Details
Announcement Title
Placements
Date &Time of Broadcast
04-Jun-2024 19:08:48
Status
Replacement
Announcement Sub Title
Proposed Subscription of 4,100,000 New Ordinary Shares - Receipt of Approval In-Principle
Announcement Reference
SG240528OTHR57GU
Submitted By (Co./ Ind. Name)
Wu Xuedan
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.
Additional Details
Capital Amount-Old
SGD 17,485,532.94
Capital Amount-New
SGD 18,018,532.94
No. of Existing Outstanding Shares
27,600,000
New Shares Issued
4,100,000
Offer Price
SGD 0.13
Attachments
Pharmesis - Placement - Approval In-Principle from the SGX-ST - 04.06.2024.pdf
Total size =61K
Related Announcements
Related Announcements
28/05/2024 18:39:28